Indegene reported FY26 revenue of ₹35,105 million, a 23.6% YoY growth, with Q4 revenue reaching ₹10,034 million, up 32.8% YoY.
Adjusted EBITDA for FY26 stood at ₹6,793 million (19.4% margin), with strong cash generation evidenced by an OCF to PAT ratio of 162%.
The company expanded its client base to 91 active relationships, adding 18 new clients and 12 new accounts with over $1 million in revenue.
Management highlighted GenAI-driven growth and recommended a final dividend of ₹2.25 per share, a 12.5% increase over FY25.